Selected 25-hydroxyvitamin D, calcium, albumin, phosphorus, and parathyroid hormone (PTH) tests can help clarify the pattern. Ulta Lab Tests provides the linked laboratory options for a plan developed with your healthcare professional. This information is educational and does not replace individualized medical care.
Celiac disease can affect bones even when digestive symptoms are mild. Impaired nutrient absorption, inflammation, low body weight, and other risk factors may contribute to reduced bone strength. Laboratory tests help investigate these contributors, while a DXA scan measures bone mineral density. The two types of assessment answer different questions.
The small intestine helps absorb nutrients needed for normal bone formation and maintenance. In untreated celiac disease, intestinal injury may reduce absorption and contribute to deficiencies. People may also restrict food groups, lose weight, or have additional factors that affect the skeleton. Bone health therefore cannot be explained by one nutrient result alone.
Low bone mineral density and impaired bone mineralization are related but distinct problems. Osteoporosis describes reduced bone strength and increased fracture susceptibility. Osteomalacia involves impaired mineralization of bone and can occur with severe or prolonged deficiencies. A clinician uses history, laboratory patterns, imaging, and sometimes specialist assessment to distinguish the relevant problems.
The European celiac management guideline published in 2026 recommends assessment based on risk factors and biochemical findings, with DXA decisions tailored to the individual. Its approach should not be turned into a claim that every person with celiac disease needs the same scan schedule or every possible bone-related blood test.
| Clinical situation | Possible laboratory focus | Other information needed |
|---|---|---|
| Established celiac disease with significant weight loss or malabsorption | Vitamin D, calcium, albumin, and selected additional tests | Dietary intake, duration of symptoms, and fracture risk. |
| Low bone density without a clear explanation | Consider tTG-IgA with total IgA if celiac disease is plausible | Age, hormonal status, medications, and other secondary causes. |
| A fracture following minor trauma | Investigation of mineral and endocrine contributors | Clinical fracture assessment and appropriate imaging. |
| Low vitamin D that persists despite a treatment plan | Review the result with calcium balance and selected PTH testing | Actual intake, adherence, absorption, and kidney health. |
| Bone pain or muscle weakness | Targeted assessment guided by examination | Symptoms are nonspecific and may need prompt evaluation. |
Older age, menopause, long-term glucocorticoid use, previous fractures, and other conditions can contribute alongside celiac disease. The presence of an intestinal diagnosis should not stop the investigation of another treatable contributor. Equally, a single low vitamin measurement should not automatically trigger a celiac label.
| Linked test | What it measures | Clinical role and limitations |
|---|---|---|
| Vitamin D, 25-hydroxy, total | The main circulating marker used to assess vitamin D status. | Low levels can support deficiency assessment; the cause and significance depend on clinical context. Higher is not always better. |
| Calcium | Total calcium in blood, including protein-bound calcium. | High or low results require interpretation. A normal value does not measure dietary adequacy or bone strength. |
| Albumin | A major circulating protein that binds some calcium. | Helps contextualize total calcium. Low albumin has several causes and is not a specific malnutrition diagnosis. |
| Phosphate as phosphorus | Circulating phosphorus involved in bone and cellular function. | Both low and high values have multiple causes, including hormonal and kidney-related influences. |
| Intact PTH | A hormone involved in calcium regulation. | Useful selectively when calcium or mineral regulation is abnormal; interpretation requires the accompanying pattern. |
| Comprehensive metabolic panel | Includes calcium, albumin, creatinine, and other chemistry measurements; kidney estimates may be reported as applicable. | Provides context for mineral balance. It does not include every bone-related hormone or vitamin. |
NIH's Office of Dietary Supplements identifies the 25-hydroxy form as the principal vitamin D status marker and notes assay and threshold differences. Use the laboratory's units and reference information, together with clinical guidance. A target chosen for one medical situation should not be presented as a universal ideal for everyone.
The tests in this table are options, not a required shopping list. For example, a person with uncomplicated follow-up may need repeat assessment of a previously low nutrient, while someone with unexplained high calcium may need an endocrine evaluation with a different sequence.
The body regulates circulating calcium closely because nerves, muscles, and many other functions depend on it. That regulation can preserve a normal blood level even while bone health is compromised. A normal serum calcium result therefore should not be used to dismiss a fracture history or an abnormal DXA scan.
Some calcium is bound to albumin. When albumin is low, total calcium may appear low without the biologically active fraction being reduced to the same degree. Clinicians interpret the protein context and may investigate further when needed. A simple correction calculation is not a universal substitute for clinical judgment, especially in complex illness or kidney disease.
Similarly, low albumin does not prove that celiac disease is causing poor nutrition. Inflammation, protein loss, and liver disease may affect it. The value becomes useful when read with weight history, dietary information, other findings, and the reason testing was ordered.
PTH helps maintain calcium balance. It can rise in response to inadequate calcium availability, vitamin D deficiency, or kidney-related disturbances. This compensatory response is often called secondary hyperparathyroidism. It is different from a parathyroid gland producing excessive hormone independently, as in primary hyperparathyroidism.
MedlinePlus explains why PTH and calcium are interpreted together. High PTH with low or normal calcium leads to a different evaluation from high PTH with high calcium. Kidney function, medication use, vitamin D status, and repeated measurements may be needed before drawing a conclusion.
| Pattern | Possible question | Avoid this assumption |
|---|---|---|
| Low vitamin D with elevated PTH and normal or low calcium | Is there a compensatory response to inadequate calcium availability or another secondary cause? | “This proves celiac disease.” |
| High calcium with PTH that is not appropriately suppressed | Does a parathyroid disorder or another condition need investigation? | “All bone abnormalities are from malabsorption.” |
| Normal calcium with reduced bone density | Which skeletal risk factors or secondary causes are present? | “Normal blood calcium means normal bones.” |
| Persistent mineral abnormalities with impaired kidney function | How is kidney disease affecting mineral regulation? | “More vitamin supplements will necessarily fix the pattern.” |
DXA, also called dual-energy X-ray absorptiometry, estimates bone mineral density. It is an imaging procedure, not a blood test. Laboratory assessment can reveal potentially treatable contributors to bone loss, while DXA helps characterize skeletal status in the appropriate clinical setting.
A clinician considers fracture history, age, severity of malabsorption, weight, medications, and other osteoporosis risks when deciding whether and when to obtain a scan. Guidelines differ in their timing recommendations. Someone with a new suspected fracture needs evaluation now; a general follow-up interval should never be interpreted as an instruction to wait.
For an expanded explanation of secondary causes, see osteoporosis and the hidden causes of bone loss. This article's narrower question is how celiac disease and mineral-related laboratory findings interact.
Unexplained low bone density becomes more suggestive of a possible absorption disorder when accompanied by recurring iron deficiency, persistent bowel symptoms, weight loss, or an affected close relative. That pattern may justify tTG-IgA with total IgA while gluten remains in the diet.
A bone-health workup does not establish a celiac diagnosis. A positive antibody screen requires the appropriate confirmation pathway, and negative testing after gluten avoidance can be misleading. Review the main celiac-testing guide before using a dietary trial as a diagnostic experiment.
After confirmed celiac disease is treated, nutritional and skeletal recovery may proceed at different rates. Correcting a blood-level deficiency is useful, but it does not demonstrate that bone density has already recovered. Continue fracture-risk assessment and any recommended imaging follow-up rather than treating a normal vitamin result as the endpoint.
Repeat testing should focus on prior abnormalities, the treatment plan, and symptoms. Record supplement products and doses, dietary intake, medication changes, and the laboratory method where possible. Do not increase calcium or vitamin D indefinitely in response to an isolated result; excessive supplementation can create its own problems.
Use the linked pages to review current testing options, prices, and collection instructions. Check whether a comprehensive metabolic panel already supplies measurements you were considering separately. Follow any fasting or timing instructions for the complete order and ask the clinician about supplements or medications rather than stopping them independently.
Bring the DXA report, fracture history, and previous laboratory results to the visit. The most useful question is not “Which bone panel is largest?” but “Which results would clarify the cause or change the next step?” Ulta Lab Tests can support access to those measurements within an appropriate care plan.
Yes. Celiac disease may be recognized through findings outside the digestive tract, including low bone density or nutrient abnormalities. These findings are not specific to celiac disease, however. A clinician considers the overall pattern and other possible causes before recommending celiac-specific testing, rather than assuming that every unexplained bone problem is intestinal in origin.
No. The body can keep blood calcium within its reference range despite reduced bone density or inadequate intake. A calcium blood test does not measure the amount of mineral in your skeleton. Fracture history, risk factors, and DXA when indicated provide information that a routine chemistry measurement cannot supply.
Vitamin D, 25-hydroxy, total is the usual blood test for vitamin D status. Its interpretation depends on units, the laboratory method, and the clinical situation. A low result can have several causes besides malabsorption. The clinician should connect the finding with dietary intake, supplements, kidney health, and the reason testing was requested.
Some calcium in blood is bound to albumin, so the protein level affects the interpretation of total calcium. Albumin testing helps provide that context. It does not itself diagnose a calcium disorder or malnutrition. When results are difficult to reconcile with the clinical picture, the clinician may investigate further rather than relying on a simple calculation.
No. PTH may rise as a compensatory response to low vitamin D, inadequate calcium availability, or kidney disease, among other explanations. Its meaning depends particularly on the accompanying calcium result. A clinician distinguishes secondary responses from primary parathyroid disease using the whole pattern and additional evaluation when needed.
No. Blood tests assess possible contributors to bone disease, while DXA measures bone mineral density. Neither gives all the information contained in the other. The clinician decides whether a scan is indicated from age, fracture history, malabsorption severity, medications, and other risk factors, and then interprets imaging and laboratory results together.
Not automatically. Low vitamin D is common and may reflect several factors unrelated to celiac disease. Testing becomes more relevant when the deficiency is persistent or accompanied by suggestive symptoms, other nutrient abnormalities, unexplained low bone density, or a close family history. The goal is targeted evaluation rather than a diagnosis based on one nutrient value.
Recovery varies with age, baseline bone loss, nutrition, duration of disease, and other risk factors. Treating confirmed celiac disease and correcting deficiencies can support bone health, but neither guarantees complete recovery or eliminates fracture risk. Follow-up may include laboratory reassessment, dietary support, imaging, and additional bone-specific care based on the individual's needs.
Review the relevant laboratory options with your clinician alongside any fracture or DXA findings. An individualized plan can clarify whether the concern is nutrient status, mineral regulation, celiac activity, or another cause. The digestive health testing guide explains how this focused evaluation fits within broader digestive care.
| Category | Test or panel | Role |
|---|---|---|
| Vitamin status | Vitamin D, 25-Hydroxy, Total | Assesses vitamin D status in the context of absorption, intake, supplements, and bone-health concerns. |
| Mineral assessment | Calcium | Measures total blood calcium. A normal result does not establish normal bone density. |
| Calcium interpretation | Albumin | Provides protein-binding context when interpreting total calcium. |
| Mineral assessment | Phosphate as Phosphorus | Evaluates circulating phosphorus alongside other mineral, hormonal, and kidney findings. |
| Conditional hormone assessment | PTH, Intact | Helps investigate abnormal calcium or mineral regulation when indicated. |
| Metabolic and kidney context | Comprehensive Metabolic Panel — CMP | Provides chemistry context, including creatinine, calcium, and albumin. Check for overlap before ordering separate components. |
| Celiac evaluation when clinically indicated | Tissue Transglutaminase IgA Antibody — tTG-IgA | Supports evaluation when unexplained bone findings or associated symptoms raise suspicion for celiac disease. |
| Celiac evaluation when clinically indicated | Total Immunoglobulin A — Total IgA | Helps identify IgA deficiency that can affect interpretation of IgA-based celiac testing. |
| Priority | Related Health Area | Role |
|---|---|---|
| 1 | Celiac Disease Tests | Celiac evaluation when unexplained bone findings or other clinical clues warrant testing. |
| 2 | Bone and Joint Tests | Laboratory assessment of mineral regulation and contributors to bone disease. |
| 3 | Vitamin and Mineral Tests | Assessment of selected nutritional abnormalities and follow-up. |
Celiac disease can contribute to bone problems through malabsorption and other clinical factors. Laboratory tests investigate nutrient and mineral contributors, while DXA measures bone mineral density.
Related tests: Vitamin D, 25-Hydroxy, Total, Calcium, Albumin, Phosphate as Phosphorus, PTH, Intact, Comprehensive Metabolic Panel, Tissue Transglutaminase IgA Antibody Test, IgA Test.
Ulta Lab Tests provides access to the linked laboratory options to support a clinician-directed evaluation.
Educational information only; laboratory results require clinical interpretation and do not replace individualized medical care.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
